These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8356545)

  • 1. [Possible exploitation of a pharmacovigilance center concerning the risk of teratogenesis].
    Guilhem D; Castex V; Soubrié C
    Therapie; 1993; 48(1):47-9. PubMed ID: 8356545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?
    Auffret M; Bernard-Phalippon N; Dekemp J; Carlier P; Gervoise Boyer M; Vial T; Gautier S
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():188-192. PubMed ID: 27865944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenicity of recently introduced medications in human pregnancy.
    Lo WY; Friedman JM
    Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tinidazole treatment during pregnancy and teratogenesis.
    Czeizel AE; Kazy Z; Vargha P
    Int J Gynaecol Obstet; 2003 Dec; 83(3):305-6. PubMed ID: 14643044
    [No Abstract]   [Full Text] [Related]  

  • 6. Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testing.
    Cavadino A; Prieto-Merino D; Morris JK
    Br J Clin Pharmacol; 2019 Feb; 85(2):356-365. PubMed ID: 30350871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residential mobility during pregnancy: implications for environmental teratogenesis.
    Khoury MJ; Stewart W; Weinstein A; Panny S; Lindsay P; Eisenberg M
    J Clin Epidemiol; 1988; 41(1):15-20. PubMed ID: 3335868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study.
    Vauzelle C; Beghin D; Cournot MP; Elefant E
    Reprod Toxicol; 2013 Apr; 36():98-103. PubMed ID: 23207166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
    De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
    Acta Obstet Gynecol Scand; 2007; 86(1):99-101. PubMed ID: 17230297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register.
    Lee C; Rizzi S; Bierrenbach AL; Antunes L; Nissinen NM; Rocha O; Campbell J; Minassian C; Hodgson S; Broe A
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5761. PubMed ID: 38362650
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
    Seto A; Einarson T; Koren G
    Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.
    Damkier P; Broe A
    JAMA; 2020 Jan; 323(4):374-376. PubMed ID: 31990303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project.
    Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcome.
    Dathe K; Padberg S; Hultzsch S; Meixner K; Tissen-Diabaté T; Meister R; Beck E; Schaefer C
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1197-1204. PubMed ID: 28771890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome after in utero exposure to colchicine.
    Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
    Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of congenital defects in the children of mothers who used medications in the first trimester of pregnancy in the Czech Republic 1996-2001].
    Sípek A; Gregor V; Velebil P; Horácek J; Masátová D; Svĕtnicová K
    Ceska Gynekol; 2003 Nov; 68(6):401-19. PubMed ID: 15042851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.